Core MRI technology provides most advanced scanners for
highest intraoperative image quality and best workflow
available
WINNIPEG,
Aug. 21, 2014 /PRNewswire/ - IMRIS
Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today
announced that the Company has received Health Canada licensing to
incorporate next generation MRI core technology into the VISIUS
Surgical Theatre for sales and marketing in the country.
(Photo:
http://photos.prnewswire.com/prnh/20140821/138341)
This newest imaging technology, based on the Siemens Aera 1.5T
(Tesla) and Skyra 3.0T MRI scanners, helps IMRIS deliver even
better image quality, faster 3D image acquisition, and improved
ease-of-use and workflow during surgical procedures using
intraoperative MRI (iMRI). The Company received United States Food
and Drug Administration (FDA) clearance for these advancements in
February 2014 and last month received
CE mark authorization in Europe.
"Hospitals who adopt this technology in our VISIUS solution will
have access to the highest quality MR applications and images
within the operating room setting," said IMRIS President and CEO
Jay D. Miller. "This latest and
unequaled imaging technology in the hands of neurosurgeons is
improving patient outcomes and making newer minimally-invasive
treatment options for brain tumors, epilepsy and other therapies
work better."
Inside a VISIUS Surgical Theatre equipped with high-field iMRI,
surgeons have on-demand access to real-time data and
state-of-the-art imaging during the procedure as the scanner
uniquely moves on ceiling-mounted rails. The Company also designs
and manufactures proprietary intraoperative CTs, head fixation
devices, imaging coils, and OR tables for use in this unique and
multifunctional intraoperative environment.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing
image guided therapy solutions through its VISIUS Surgical Theatre
- a revolutionary, multifunctional surgical environment that
provides unmatched intraoperative vision to clinicians to assist in
decision making and enhance precision in treatment. The multi-room
suites incorporate diagnostic quality high-field MR, CT and angio
modalities accessed effortlessly in the operating room setting.
VISIUS Surgical Theatres serve the neurosurgical, spinal,
cardiovascular and cerebrovascular markets and have been selected
by 61 leading medical institutions around the world.
SOURCE IMRIS Inc.